Elanco Animal Health Incorporated Common Stock (ELAN) is a publicly traded Healthcare sector company. As of May 21, 2026, ELAN trades at $20.80 with a market cap of $9.95B and a P/E ratio of -41.81. ELAN moved +5.25% today. Year to date, ELAN is -9.54%; over the trailing twelve months it is +59.40%. Its 52-week range spans $8.02 to $27.72. Analyst consensus is strong buy with an average price target of $29.18. Rallies surfaces ELAN's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
ELAN financials on Rallies include revenue, net income, EPS, valuation metrics, market cap, price history, and balance sheet context. ELAN recently traded at $20.80. Market cap is $9.95B. P/E ratio is -41.81. Revenue is $4.89B.
| Metric | Value |
|---|---|
| Price | $20.80 |
| Market Cap | $9.95B |
| P/E Ratio | -41.81 |
| EPS | $-0.50 |
| Dividend Yield | 0.00% |
| 52-Week High | $27.72 |
| 52-Week Low | $8.02 |
| Volume | 152 |
| Avg Volume | 0 |
| Revenue (TTM) | $4.89B |
| Net Income | $-242.00M |
| Gross Margin | 55.06% |
| Year | Revenue | Net Income | EPS |
|---|---|---|---|
| 2025 | $4.71B | $-232.00M | $-0.47 |
| 2024 | $4.44B | $338.00M | $0.68 |
| 2023 | $4.42B | $-1.23B | $-2.50 |
| 2022 | $4.41B | $-78.00M | $-0.16 |
12 analysts cover ELAN: 0 strong buy, 11 buy, 1 hold, 0 sell, 0 strong sell. Consensus rating is strong buy. Average price target: $29.18.